Skip to main content
. Author manuscript; available in PMC: 2019 Oct 28.
Published in final edited form as: Arch Toxicol. 2018 Jul 19;92(9):2859–2874. doi: 10.1007/s00204-018-2268-y

Figure 4. Top enriched pathways (GO Terms) induced by rosiglitazone (A), LG100268 (B) and TBT (C).

Figure 4.

Pathway enrichment analyses were performed using a hypergeometric distribution based test to determine the gene sets (Gene Ontology terms from GO database) over-represented in the lists of significant (fdr< 0.05) differentially expressed genes.